Understanding Crigler-Najjar Syndrome: Symptoms, Causes, Diagnosis, and Treatment

Written by Medicover Team and Medically Reviewed by Dr A Venkateshwar Rao , Gastroenterologists Medical

Crigler-Najjar Syndrome are a rare inherited genetic disorder that disrupts the body's ability to properly break down bilirubin, a waste product formed from the breakdown of red blood cells. This condition results from mutations in the UGT1A1 gene, which encodes the enzyme uridine diphosphate-glucuronosyltransferase (UGT).

The UGT enzyme is essential for converting bilirubin into a water-soluble form that can be excreted from the body. Without functional UGT enzyme activity, unconjugated bilirubin accumulates in the blood, leading to jaundice and, in severe cases, neurological damage.

What are the Causes of Crigler-Najjar Syndrome?

Crigler-Najjar Syndrome is primarily caused by mutations in the UGT1A1 gene, which encodes the enzyme uridine diphosphate-glucuronosyltransferase (UGT). This enzyme is vital for converting bilirubin into a water-soluble form that can be excreted from the body. In patients with Crigler-Najjar Syndrome, the UGT enzyme is either deficient or entirely absent, leading to the accumulation of unconjugated bilirubin in the bloodstream.

Genetic Mechanisms

The UGT1A1 gene mutations can be inherited in an autosomal recessive manner. This means both parents must carry one copy of the mutated gene to pass the disorder onto their offspring. There are two types of Crigler-Najjar Syndrome: Type I and Type II. Type I is the more severe form, characterized by a complete absence of UGT enzyme activity. Type II, also known as Arias Syndrome, is less severe and involves reduced enzyme activity.

When Should You See a Doctor for Crigler-Najjar Syndrome?

Early consultation with a pediatrician, neonatologist, genetic specialist, or liver specialist is essential, especially in newborns with persistent jaundice.

What are the Symptoms for Crigler-Najjar Syndrome?

Crigler-Najjar syndrome primarily presents with severe jaundice due to high levels of bilirubin in the blood. Symptoms may include yellowing of the skin and eyes, lethargy, poor feeding in infants, and in severe cases, neurological complications such as kernicterus, which can lead to muscle stiffness, hearing loss, or developmental delays.

Neonatal Jaundice

One of the most prominent symptoms of Crigler-Najjar Syndrome is neonatal jaundice, which manifests as a yellowing of the skin and eyes within the first few days of life. This is due to elevated levels of unconjugated bilirubin.

Neurological Complications

If left untreated, high levels of bilirubin can lead to bilirubin encephalopathy or kernicterus, a condition characterized by severe and potentially irreversible neurological damage. Symptoms may include muscle rigidity, hearing loss, and ataxia.

Chronic Jaundice

Patients with Crigler-Najjar Syndrome often experience persistent jaundice, even beyond the neonatal period. This chronic jaundice can result in fatigue, poor feeding, and irritability.

How is the Crigler-Najjar Syndrome Diagnosed?

Crigler-Najjar syndrome is diagnosed through blood tests that reveal elevated levels of unconjugated bilirubin, along with normal liver function tests. Genetic testing is used to confirm mutations in the UGT1A1 gene, and additional evaluations help distinguish it from other causes of neonatal jaundice.

Blood Tests

The initial diagnosis usually involves blood tests to measure bilirubin levels. Elevated levels of unconjugated bilirubin in the absence of hemolysis (destruction of red blood cells) can indicate Crigler-Najjar Syndrome.

Genetic Testing

Definitive diagnosis is achieved through genetic testing, which identifies mutations in the UGT1A1 gene. This is particularly important for distinguishing between Type I and Type II Crigler-Najjar Syndrome, as the treatment approach may differ.

Liver Biopsy

In some cases, a liver biopsy may be performed to assess the activity of the UGT enzyme. However, this is less commonly used due to the invasive nature of the procedure and the availability of genetic testing.

What are the Treatment Options for Crigler-Najjar Syndrome?

Treatment for Crigler-Najjar syndrome focuses on reducing bilirubin levels and preventing complications. Options include intensive phototherapy, medications such as phenobarbital (mainly effective in type 2), and in severe cases, liver transplantation. Supportive care and regular monitoring are essential to manage symptoms and prevent neurological damage.

Phototherapy

Phototherapy is one of the primary treatments for Crigler-Najjar Syndrome, especially in infants. The exposure to blue light helps convert unconjugated bilirubin into a water-soluble form that can be excreted through urine. For Type I patients, continuous phototherapy may be required, whereas Type II patients might need it less frequently.

Liver Transplant

For patients with Type I Crigler-Najjar Syndrome, a liver transplant may be considered, especially if phototherapy becomes less effective. A transplant can provide a new liver with functional UGT enzymes, effectively curing the metabolic defect.

Pharmacological Treatments

Patients with Type II Crigler-Najjar Syndrome may benefit from pharmacological treatments such as phenobarbital, which can enhance the activity of the residual UGT enzyme. However, this treatment is generally ineffective for Type I patients.

Managing Bilirubin Levels

Regular monitoring of bilirubin levels is crucial in managing Crigler-Najjar Syndrome. In addition to phototherapy and pharmacological treatments, lifestyle adjustments such as avoiding fasting and ensuring adequate hydration can help manage bilirubin levels.

Your health is everything - prioritize your well-being today.

Consult Crigler Najjar Syndrome Doctors Today

What is the Recovery Process for Crigler-Najjar Syndrome?

Crigler-Najjar Syndrome is a lifelong condition, but proper management can improve outcomes and quality of life.